Wednesday – 20th November 2024 – Conference Day 2 - ET (Eastern Time, GMT-05:00)
Wednesday – 20th November 2024 – Conference Day 2 - ET (Eastern Time, GMT-05:00)
Attendees are invited to engage directly in a small group demonstrations. Here company needs are matched with capabilities in a highly interactive and intimate setting.
• Who Does What — Features and Facets Explored
• Solution Synergies — Tools Right-Sized to Your Needs
• Contract pharmacy arrangements
• Reporting requirements
CPE Credits Available: 0.9
- Matthew Pellegrini - Sr. Director - Revenue Optimization Contracting & Compliance N.A., Teva Pharmaceuticals
CPE Credits Available: 0.9
- Jeff Baab - Vice President, Operational Consulting, IntegriChain
- Strategic and financial implications of benefit redesign, inflation rebates, price negotiations
- The importance of strategy
- Coordinating with salesforce to leverage optimal return
- Utilizing GTN to optimize sales and understand target channels
- Impact on GTN and financial reporting
- Updates for reporting procedures
- AMP Cap removal
- Rosalind Davis - Director, Government Pricing and Contracts, CSL Vifor
- Timothy Kocses - Executive Director, US Commercial Controller, Bristol Myers Squibb
- Michael Domanico - Vice President Finance, Revenue, Sandoz
- Benjamin Strawsburg - Commercial Contracting Partner, Contracts and Pricing, UCB
• Therapy areas and their impact on GTN
• Commercial approach for biosimilars
• Pricing management within a GPO/HPO
• Direct buying vs Wholesaler buying
• Tough decisions for manufacturers in the new age world
• Loss of margins owing to therapeutic mix
CPE Credits Available: 1.2
• Feedback loops
o Gaining insights for better forecasts
o Pressure testing o Team collaboration
• Accrual Methodology
o Data alignment
o GTN and finance model comparisons
CPE Credits Available: 1.2
- Prakash Chainani - Vice President – Finance, HR & IT, Lifestar Pharma LLC (a Mankind Group Company)
- Christopher Wang - Corporate Controller, Revance Therapeutics
- Michael Christiano - Director, Revenue, Ardelyx
- Robert Lucchesi - Director, FP&A Sales Reporting & Forecasting, Novo Nordisk
• Estimating revenue versus liability on financial reports
• Data driven insights surrounding expectations for disputes
• Challenges deriving from certain discount models
• Development of a channel summary
• Pipeline liability
CPE Credits Available: 0.9
- Ranish Singhvi - Vice President, Finance, Accord Healthcare
• Affordability pressure stemming from policy changes and what to expect moving forward
• The effect on GTN and key takeaways for consideration o Utilization and price pressure
• Evaluating tradeoff between rebates and access
• Co-pay assistance programs
CPE Credits Available: 0.9
- Lisa Mostovoy - SVP, Next Gen Commercialization, Population Health Partners
- Chris Rocco - Senior Director, Market Access Data, Reporting & Analytics, GSK
- Sherri Cirota - Executive Director, Contracts & Pricing, Alkermes, Inc.
- Edward McAdam - Director, Government Pricing, Contracting Operations & Analytics, Indivior